Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

| More on:
Two brokers analysing stocks.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It was another busy week for Australia's top brokers. This has led to the release of a number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone:

CSL Ltd (ASX: CSL)

According to a note out of Morgan Stanley, its analysts have retained their overweight rating and $303.00 price target on this biotherapeutics company's shares. This follows news that CSL has received US Food & Drug Administration (FDA) approval for its Andembry therapy. This product aims to help prevent attacks of hereditary angioedema (HAE). While Morgan Stanley was pleased with the news, the broker was expecting its approval and had already factored it into its forecasts. Outside this, Morgan Stanley is forecasting low-teen annual earnings growth through to FY 2028. But it sees potential to accelerate this growth through a combination of lower costs and share buybacks. The CSL share price ended last week at $240.21.

Life360 Inc (ASX: 360)

Another note out of Morgan Stanley reveals that its analysts have retained their overweight rating on this location technology company's shares with an increased price target of $40.00. According to the note, the broker believes that Life360 is well-positioned to deliver further strong growth over the medium term. It highlights that it has one of the fast-growing userbases and is supported by the network effect and word of mouth. The latter should be supportive of lower customer acquisition costs compared to what other companies have to pay. Overall, in light of the above, the broker sees potential for Life360 to outperform the market's expectations in the medium term. The Life360 share price was fetching $31.94 at the end of last week.

Zip Co Ltd (ASX: ZIP)

Analysts at Ord Minnett have retained their buy rating on this buy now pay later provider's shares with an increased price target of $3.40. According to the note, the broker believes that Zip is in a great place right now following its second guidance update in less than three months. Ord Minnett is particularly pleased with the strong momentum that is being seen in the United States market. This is despite operating in a challenging macro environment. Together with the benefits of falling interest rates, the broker feels very positive about the company's outlook and believes it strong form can continue. The Zip share price was trading at $2.87 when the market closed on Friday.

Motley Fool contributor James Mickleboro has positions in CSL and Life360. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Life360, and Zip Co. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man looking at his laptop and thinking.
Broker Notes

Buy, hold, sell: Fortescue, Qantas, and WiseTech shares

Are these popular shares in the buy zone? Let's find out what analysts are saying.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Buy, hold, sell: Breville, Catalyst Metals, and Goodman shares

Let's see what analysts at Morgans are saying about these top stocks.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Buy, hold, sell: Light & Wonder, NAB, and Woodside shares

Morgans has given its verdict on these popular stocks.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Resources Shares

2 ASX mining shares to buy for 2026

Macquarie has buy ratings on this ASX copper mining share and ASX gold mining stock.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Broker Notes

Buy, hold, sell: Amcor, ANZ, and Macquarie shares

Does a leading broker think investors should be buying these blue chips? Let's find out.

Read more »

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Broker Notes

Buy, hold, sell: CBA, REA Group, and Xero shares

Morgans has given its verdict on these popular stocks. Let's see if it is bullish on them.

Read more »